The Fanconi anemia pathway and the DNA interstrand cross-links repair

Biochimie

Volumn 85, Issue 11, 2003, Pages 1175-1184

  Rosselli, Filippo ^a   Briot, Delphine ^a   Pichierri, Pietro ^a  

^a CNRS   (France)

Author keywords

Cross links; DNA repair; Fanconi anemia; S phase checkpoint

Indexed keywords

ATM PROTEIN; BRCA1 PROTEIN; FANCONI ANEMIA PROTEIN; MRE11 PROTEIN; PROTEIN; PROTEIN BLM; PROTEIN NSB1; PROTEIN XPF; RAD50 PROTEIN; UNCLASSIFIED DRUG;

BONE MARROW DEPRESSION; CANCER SUSCEPTIBILITY; CELL CYCLE; CELL FUNCTION; CHROMOSOME; CLINICAL FEATURE; DNA CROSS LINKING; DNA DAMAGE; DNA REPAIR; FANCONI ANEMIA; GENE ISOLATION; GENETICS; HUMAN; MOLECULAR BIOLOGY; NONHUMAN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW;

EID: 0942289901     PISSN: 03009084     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biochi.2003.11.002     Document Type: Short Survey

References (146)

1. Dronkert M.L., Kanaar R. Repair of DNA interstrand cross-links. Mutat. Res. 486:2001;217-247.
2. McHugh P.J., Spanswick V.J., Hartley J.A. Repair of DNA interstrand crosslinks: molecular mechanisms and clinical relevance. Lancet Oncol. 2:2001;483-490.
3. Zhang N., Lu X., Zhang X., Peterson C.A., Legerski R.J. hMutSbeta is required for the recognition and uncoupling of psoralen interstrand cross-links in vitro. Mol. Cell. Biol. 22:2002;2388-2397.
4. De Silva I.U., McHugh P.J., Clingen P.H., Hartley J.A. Defining the roles of nucleotide excision repair and recombination in the repair of DNA interstrand cross-links in mammalian cells. Mol. Cell. Biol. 20:2000;7980-7990.
5. Hoy C.A., Thompson L.H., Mooney C.L., Salazar E.P. Defective DNA cross-link removal in Chinese hamster cell mutants hypersensitive to bifunctional alkylating agents. Cancer Res. 45:1985;1737-1743.
6. Wang X., Peterson C.A., Zheng H., Nairn R.S., Legerski R.J., Li L. Involvement of nucleotide excision repair in a recombination-independent and error-prone pathway of DNA interstrand cross-link repair. Mol. Cell. Biol. 21:2001;713-720.
7. Kuraoka I., Kobertz W.R., Ariza R.R., Biggerstaff M., Essigmann J.M., Wood R.D. Repair of an interstrand DNA cross-link initiated by ERCC1-XPF repair/recombination nuclease. J. Biol. Chem. 275:2000;26632-26636.
8. Gaillard P.H., Wood R.D. Activity of individual ERCC1 and XPF subunits in DNA nucleotide excision repair. Nucleic Acids Res. 29:2001;872-879.
9. Essers J., Hendriks R.W., Swagemakers S.M., Troelstra C., de Wit J., Bootsma D., Hoeijmakers J.H., Kanaar R. Disruption of mouse RAD54 reduces ionizing radiation resistance and homologous recombination. Cell. 89:1997;195-204.
10. Liu N., Lamerdin J.E., Tebbs R.S., Schild D., Tucker J.D., Shen M.R., Brookman K.W., Siciliano M.J., Walter C.A., Fan W., Narayana L.S., Zhou Z.Q., Adamson A.W., Sorensen K.J., Chen D.J., Jones N.J., Thompson L.H. XRCC2 and XRCC3, new human Rad51-family members, promote chromosome stability and protect against DNA cross-links and other damages. Mol. Cell. 1:1998;783-793.
11. Muller C., Christodoulopoulos G., Salles B., Panasci L. DNA-dependent protein kinase activity correlates with clinical and in vitro sensitivity of chronic lymphocytic leukemia lymphocytes to nitrogen mustards. Blood. 92:1998;2213-2219.
12. Takata M., Sasaki M.S., Sonoda E., Morrison C., Hashimoto M., Utsumi H., Yamaguchi-Iwai Y., Shinohara A., Takeda S. Homologous recombination and non-homologous end-joining pathways of DNA double-strand break repair have overlapping roles in the maintenance of chromosomal integrity in vertebrate cells. EMBO J. 17:1998;5497-5508.
13. Akkari Y.M., Bateman R.L., Reifsteck C.A., Olson S.B., Grompe M. DNA replication is required to elicit cellular responses to psoralen-induced DNA interstrand cross-links. Mol. Cell. Biol. 20:2000;8283-8289.
14. Alter B.P. Clinical features of Fanconi's anemia. Young M.S., Alter B.P. Aplastic Anemia, Acquired and Inherited. 1994;275-309 W. B. Saunders, Philadelphia.
15. Alter B.P. Cancer in Fanconi anemia, 1927-2001. Cancer. 97:2003;425-440.
16. Rosenberg P.S., Greene M.H., Alter B.P. Cancer incidence in persons with Fanconi anemia. Blood. 101:2003;822-826.
17. Alter B.P. Leukemia and preleukemia in Fanconi's anemia. Cancer Genet. Cytogenet. 58:1992;206-208. (discussion 209).
18. Alter B.P. Fanconi's anemia and malignancies. Am. J. Hematol. 53:1996;99-110.
19. Dutrillaux B., Couturier J., Viegas-Pequignot E., Schaison G. Localization chromatid breaks in Fanconi's anemia, using three consecutive stains. Hum. Genet. 37:1977;65-71.
20. Auerbach A.D., Wolman S.R. Susceptibility of Fanconi's anaemia fibroblasts to chromosome damage by carcinogens. Nature. 261:1976;494-496.
21. Dutrillaux B., Aurias A., Dutrillaux A.M., Buriot D., Prieur M. The cell cycle of lymphocytes in Fanconi anemia. Hum. Genet. 62:1982;327-332.
22. Latt S.A., Kaiser T.N., Lojewski A., Dougherty C., Juergens L., Brefach S., Sahar E., Gustashaw K., Schreck R.R., Powers M., Lalande M. Cytogenetic and flow cytometric studies of cells from patients with Fanconi's anemia. Cytogenet. Cell Genet. 33:1982;133-138.
23. Miglierina R., Le Coniat M., Berger R. A simple diagnostic test for Fanconi anemia by flow cytometry. Anal. Cell Pathol. 3:1991;111-118.
24. Berger R., Le Coniat M., Gendron M.C. Fanconi anemia. Chromosome breakage and cell cycle studies. Cancer Genet. Cytogenet. 69:1993;13-16.
25. Fabio T., Crescenzio N., Saracco P., Leone L., Ponzio G., Ramenghi U. Cell cycle analysis in the diagnosis of Fanconi's anemia. Haematologica. 85:2000;431-432.
26. Auerbach A.D., Warburton D., Bloom A.D., Chaganti R.S. Preliminary communication: prenatal detection of the Fanconi anemia gene by cytogenetic methods. Am. J. Hum. Genet. 31:1979;77-81.
27. Auerbach A.D., Adler B., Chaganti R.S. Prenatal and postnatal diagnosis and carrier detection of Fanconi anemia by a cytogenetic method. Pediatrics. 67:1981;128-135.
28. Cervenka J., Arthur D., Yasis C. Mitomycin C test for diagnostic differentiation of idiopathic aplastic anemia and Fanconi anemia. Pediatrics. 67:1981;119-127.
29. Voss R., Kohn G., Shaham M., Benzur Z., Arnon J., Ornoy A., Yaffe H., Golbus M., Auerbach A.D. Prenatal diagnosis of Fanconi anemia. Clin. Genet. 20:1981;185-190.
30. Cohen M.M., Simpson S.J., Honig G.R., Maurer H.S., Nicklas J.W., Martin A.O. The identification of Fanconi anemia genotypes by clastogenic stress. Am. J. Hum. Genet. 34:1982;794-810.
31. Marx M.P., Dawson B., Heyns A.D. Prenatal diagnosis of Fanconi's anemia. S. Afr. Med. J. 62:1982;348.
32. Bigelow S.B., Rary J.M., Bender M.A. G2 chromosomal radiosensitivity in Fanconi's anemia. Mutat. Res. 63:1979;189-199.
33. Parshad R., Sanford K.K., Jones G.M. Chromatid damage after G2 phase x-irradiation of cells from cancer-prone individuals implicates deficiency in DNA repair. Proc. Natl. Acad. Sci. USA. 80:1983;5612-5616.
34. Duckworth-Rysiecki G., Taylor A.M. Effects of ionizing radiation on cells from Fanconi's anemia patients. Cancer Res. 45:1985;416-420.
35. Parshad R., Sanford K.K., Jones G.M. Chromosomal radiosensitivity during the G2 cell-cycle period of skin fibroblasts from individuals with familial cancer. Proc. Natl. Acad. Sci. USA. 82:1985;5400-5403.
36. Darroudi F., Vyas R.C., Vermeulen S., Natarajan A.T. G2 radiosensitivity of cells derived from cancer-prone individuals. Mutat. Res. 328:1995;83-90.
37. Joenje H., Arwert F., Eriksson A.W., de Koning H., Oostra A.B. Oxygen-dependence of chromosomal aberrations in Fanconi's anaemia. Nature. 290:1981;142-143.
38. Joenje H., Oostra A.B. Effect of oxygen tension on chromosomal aberrations in Fanconi anaemia. Hum. Genet. 65:1983;99-101.
39. Joenje H., Oostra A.B. Oxygen-induced cytogenetic instability in normal human lymphocytes. Hum. Genet. 74:1986;438-440.
40. Gille J.J., Wortelboer H.M., Joenje H. Antioxidant status of Fanconi anemia fibroblasts. Hum. Genet. 77:1987;28-31.
41. Takeuchi T., Morimoto K. Increased formation of 8-hydroxydeoxyguanosine, an oxidative DNA damage, in lymphoblasts from Fanconi's anemia patients due to possible catalase deficiency. Carcinogenesis. 14:1993;1115-1120.
42. Liebetrau W., Runge T.M., Baumer A., Henning C., Gross O., Schindler D., Poot M., Hoehn H. Exploring the role of oxygen in Fanconi's anemia. Recent Results Cancer Res. 143:1997;353-367.
43. Ruppitsch W., Meisslitzer C., Weirich-Schwaiger H., Klocker H., Scheidereit C., Schweiger M., Hirsch-Kauffmann M. The role of oxygen metabolism for the pathological phenotype of Fanconi anemia. Hum. Genet. 99:1997;710-719.
44. Centurion S.A., Kuo H.R., Lambert W.C. Damage-resistant DNA synthesis in Fanconi anemia cells treated with a DNA cross-linking agent. Exp. Cell Res. 260:2000;216-221.
45. Sala-Trepat M., Rouillard D., Escarceller M., Laquerbe A., Moustacchi E., Papadopoulo D. Arrest of S-phase progression is impaired in Fanconi anemia cells. Exp. Cell Res. 260:2000;208-215.
46. Akkari Y.M., Bateman R.L., Reifsteck C.A., D'Andrea A.D., Olson S.B., Grompe M. The 4N cell cycle delay in Fanconi anemia reflects growth arrest in late S phase. Mol. Genet. Metab. 74:2001;403-412.
47. Rosselli F., Sanceau J., Wietzerbin J., Moustacchi E. Abnormal lymphokine production: a novel feature of the genetic disease Fanconi anemia. I. Involvement of interleukin-6. Hum. Genet. 89:1992;42-48.
48. Bagby G.C. Jr, Segal G.M., Auerbach A.D., Onega T., Keeble W., Heinrich M.C. Constitutive and induced expression of hematopoietic growth factor genes by fibroblasts from children with Fanconi anemia. Exp. Hematol. 21:1993;1419-1426.
49. Bagnara G.P., Bonsi L., Strippoli P., Ramenghi U., Timeus F., Bonifazi F., Bonafe M., Tonelli R., Bubola G., Brizzi M.F., et al. Production of interleukin 6, leukemia inhibitory factor and granulocyte-macrophage colony stimulating factor by peripheral blood mononuclear cells in Fanconi's anemia. Stem Cells. 11:1993;137-143.
50. Schultz J.C., Shahidi N.T. Tumor necrosis factor-alpha overproduction in Fanconi's anemia. Am. J. Hematol. 42:1993;196-201.
51. Rosselli F., Sanceau J., Gluckman E., Wietzerbin J., Moustacchi E. Abnormal lymphokine production: a novel feature of the genetic disease Fanconi anemia. II. In vitro and in vivo spontaneous overproduction of tumor necrosis factor alpha. Blood. 83:1994;1216-1225.
52. Haneline L.S., Broxmeyer H.E., Cooper S., Hangoc G., Carreau M., Buchwald M., Clapp D.W. Multiple inhibitory cytokines induce deregulated progenitor growth and apoptosis in hematopoietic cells from Fac-/- mice. Blood. 91:1998;4092-4098.
53. Rey J.P., Scott R., Muller H. Apoptosis is not involved in the hypersensitivity of Fanconi anemia cells to mitomycin C. Cancer Genet. Cytogenet. 75:1994;67-71.
54. Rosselli F., Ridet A., Soussi T., Duchaud E., Alapetite C., Moustacchi E. p53-dependent pathway of radio-induced apoptosis is altered in Fanconi anemia. Oncogene. 10:1995;9-17.
55. Clarke A.A., Philpott N.J., Gordon-Smith E.C., Rutherford T.R. The sensitivity of Fanconi anaemia group C cells to apoptosis induced by mitomycin C is due to oxygen radical generation, not DNA crosslinking. Br. J. Haematol. 96:1997;240-247.
56. Monti D., Macchioni S., Guido M., Pagano G., Zatterale A., Calzone R., Cossarizza A., Straface E., Malorni W., Franceschi C. Resistance to apoptosis in Fanconi's anaemia. An ex vivo study in peripheral blood mononuclear cells. FEBS Lett. 409:1997;365-369.
57. Rathbun R.K., Faulkner G.R., Ostroski M.H., Christianson T.A., Hughes G., Jones G., Cahn R., Maziarz R., Royle G., Keeble W., Heinrich M.C., Grompe M., Tower P.A., Bagby G.C. Inactivation of the Fanconi anemia group C gene augments interferon-gamma-induced apoptotic responses in hematopoietic cells. Blood. 90:1997;974-985.
58. Ridet A., Guillouf C., Duchaud E., Cundari E., Fiore M., Moustacchi E., Rosselli F. Deregulated apoptosis is a hallmark of the Fanconi anemia syndrome. Cancer Res. 57:1997;1722-1730.
59. Koh P.S., Hughes G.C., Faulkner G.R., Keeble W.W., Bagby G.C. The Fanconi anemia group C gene product modulates apoptotic responses to tumor necrosis factor-alpha and Fas ligand but does not suppress expression of receptors of the tumor necrosis factor receptor superfamily. Exp. Hematol. 27:1999;1-8.
60. Guillouf C., Wang T.S., Liu J., Walsh C.E., Poirier G.G., Moustacchi E., Rosselli F. Fanconi anemia C protein acts at a switch between apoptosis and necrosis in mitomycin C-induced cell death. Exp. Cell Res. 246:1999;384-394.
61. Guillouf C., Vit J.P., Rosselli F. Loss of the Fanconi anemia group C protein activity results in an inability to activate caspase-3 after ionizing radiation. Biochimie. 82:2000;51-58.
62. Rathbun R.K., Christianson T.A., Faulkner G.R., Jones G., Keeble W., O'Dwyer M., Bagby G.C. Interferon-gamma-induced apoptotic responses of Fanconi anemia group C hematopoietic progenitor cells involve caspase 8-dependent activation of caspase 3 family members. Blood. 96:2000;4204-4211.
63. de Winter J.P., Leveille F., van Berkel C.G., Rooimans M.A., van Der Weel L., Steltenpool J., Demuth I., Morgan N.V., Alon N., Bosnoyan-Collins L., Lightfoot J., Leegwater P.A., Waisfisz Q., Komatsu K., Arwert F., Pronk J.C., Mathew C.G., Digweed M., Buchwald M., Joenje H. Isolation of a cDNA representing the Fanconi anemia complementation group E gene. Am. J. Hum. Genet. 67:2000;1306-1308.
64. de Winter J.P., Rooimans M.A., van Der Weel L., van Berkel C.G., Alon N., Bosnoyan-Collins L., de Groot J., Zhi Y., Waisfisz Q., Pronk J.C., Arwert F., Mathew C.G., Scheper R.J., Hoatlin M.E., Buchwald M., Joenje H. The Fanconi anaemia gene FANCF encodes a novel protein with homology to ROM. Nat. Genet. 24:2000;15-16.
65. de Winter J.P., Waisfisz Q., Rooimans M.A., van Berkel C.G., Bosnoyan-Collins L., Alon N., Carreau M., Bender O., Demuth I., Schindler D., Pronk J.C., Arwert F., Hoehn H., Digweed M., Buchwald M., Joenje H. The Fanconi anaemia group G gene FANCG is identical with XRCC9. Nat. Genet. 20:1998;281-283.
66. Lo Ten Foe J.R., Rooimans M.A., Bosnoyan-Collins L., Alon N., Wijker M., Parker L., Lightfoot J., Carreau M., Callen D.F., Savoia A., Cheng N.C., van Berkel C.G., Strunk M.H., Gille J.J., Pals G., Kruyt F.A., Pronk J.C., Arwert F., Buchwald M., Joenje H. Expression cloning of a cDNA for the major Fanconi anaemia gene, FAA. Nat. Genet. 14:1996;320-323.
67. Howlett N.G., Taniguchi T., Olson S., Cox B., Waisfisz Q., De Die-Smulders C., Persky N., Grompe M., Joenje H., Pals G., Ikeda H., Fox E.A., D'Andrea A.D. Biallelic inactivation of BRCA2 in Fanconi anemia. Science. 297:2002;606-609.
68. Strathdee C.A., Gavish H., Shannon W.R., Buchwald M. Cloning of cDNAs for Fanconi's anaemia by functional complementation. Nature. 358:1992;434.
69. Timmers C., Taniguchi T., Hejna J., Reifsteck C., Lucas L., Bruun D., Thayer M., Cox B., Olson S., D'Andrea A.D., Moses R., Grompe M. Positional cloning of a novel Fanconi anemia gene, FANCD2. Mol. Cell. 7:2001;241-248.
70. Gillio A.P., Verlander P.C., Batish S.D., Giampietro P.F., Auerbach A.D. Phenotypic consequences of mutations in the Fanconi anemia FAC gene: an International Fanconi Anemia Registry study. Blood. 90:1997;105-110.
71. Futaki M., Yamashita T., Yagasaki H., Toda T., Yabe M., Kato S., Asano S., Nakahata T. The IVS4 + 4 A to T mutation of the Fanconi anemia gene FANCC is not associated with a severe phenotype in Japanese patients. Blood. 95:2000;1493-1498.
72. Yamashita T., Barber D.L., Zhu Y., Wu N., D'Andrea A.D. The Fanconi anemia polypeptide FACC is localized to the cytoplasm. Proc. Natl. Acad. Sci. USA. 91:1994;6712-6716.
73. Youssoufian H. Localization of Fanconi anemia C protein to the cytoplasm of mammalian cells. Proc. Natl. Acad. Sci. USA. 91:1994;7975-7979.
74. Youssoufian H. Cytoplasmic localization of FAC is essential for the correction of a prerepair defect in Fanconi anemia group C cells. J. Clin. Invest. 97:1996;2003-2010.
75. Kupfer G.M., Naf D., Suliman A., Pulsipher M., D'Andrea A.D. The Fanconi anaemia proteins, FAA and FAC, interact to form a nuclear complex. Nat. Genet. 17:1997;487-490.
76. Naf D., Kupfer G.M., Suliman A., Lambert K., D'Andrea A.D. Functional activity of the Fanconi anemia protein FAA requires FAC binding and nuclear localization. Mol. Cell. Biol. 18:1998;5952-5960.
77. Kruyt F.A., Youssoufian H. The Fanconi anemia proteins FAA and FAC function in different cellular compartments to protect against cross-linking agent cytotoxicity. Blood. 92:1998;2229-2236.
78. Garcia-Higuera I., D'Andrea A.D. Nuclear localization of the Fanconi anemia protein FANCC is required for functional activity. Blood. 93:1999;4025-4026.
79. Huber P.A., Medhurst A.L., Youssoufian H., Mathew C.G. Investigation of Fanconi anemia protein interactions by yeast two-hybrid analysis. Biochem. Biophys. Res. Commun. 268:2000;73-77.
80. de Winter J.P., van der Weel L., de Groot J., Stone S., Waisfisz Q., Arwert F., Scheper R.J., Kruyt F.A., Hoatlin M.E., Joenje H. The Fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG. Hum. Mol. Genet. 9:2000;2665-2674.
81. Pace P., Johnson M., Tan W.M., Mosedale G., Sng C., Hoatlin M., de Winter J., Joenje H., Gergely F., Patel K.J. FANCE: the link between Fanconi anaemia complex assembly and activity. EMBO J. 21:2002;3414-3423.
82. Medhurst A.L., Huber P.A., Waisfisz Q., de Winter J.P., Mathew C.G. Direct interactions of the five known Fanconi anaemia proteins suggest a common functional pathway. Hum. Mol. Genet. 10:2001;423-429.
83. Taniguchi T., D'Andrea A.D. The Fanconi anemia protein, FANCE, promotes the nuclear accumulation of FANCC. Blood. 100:2002;2457-2462.
84. Vessey C.J., Norbury C.J., Hickson I.D. Genetic disorders associated with cancer predisposition and genomic instability. Prog. Nucleic Acids Res. Mol. Biol. 63:1999;189-221.
85. Gordon S.M., Buchwald M. Fanconi anemia protein complex: mapping protein interactions in the yeast 2- and 3-hybrid systems. Blood. 102:2003;136-141.
86. Hussain S., Witt E., Huber P.A., Medhurst A.L., Ashworth A., Mathew C.G. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1. Hum. Mol. Genet. 5:2003;5.
87. Garcia-Higuera I., Taniguchi T., Ganesan S., Meyn M.S., Timmers C., Hejna J., Grompe M., D'Andrea A.D. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol. Cell. 7:2001;249-262.
88. Taniguchi T., Garcia-Higuera I., Xu B., Andreassen P.R., Gregory R.C., Kim S.T., Lane W.S., Kastan M.B., D'Andrea A.D. Convergence of the Fanconi anemia and ataxia telangiectasia signaling pathways. Cell. 109:2002;459-472.
89. Pichierri P., Averbeck D., Rosselli F. DNA cross-link-dependent RAD50/MRE11/NBS1 subnuclear assembly requires the Fanconi anemia C protein. Hum. Mol. Genet. 11:2002;2531-2546.
90. Godthelp B.C., Artwert F., Joenje H., Zdzienicka M.Z. Impaired DNA damage-induced nuclear Rad51 foci formation uniquely characterizes Fanconi anemia group D1. Oncogene. 21:2002;5002-5005.
91. Digweed M., Rothe S., Demuth I., Scholz R., Schindler D., Stumm M., Grompe M., Jordan A., Sperling K. Attenuation of the formation of DNA-repair foci containing RAD51 in Fanconi anaemia. Carcinogenesis. 23:2002;1121-1126.
92. Wang Y., Cortez D., Yazdi P., Neff N., Elledge S.J., Qin J. BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures. Genes Dev. 14:2000;927-939.
93. Bochar D.A., Wang L., Beniya H., Kinev A., Xue Y., Lane W.S., Wang W., Kashanchi F., Shiekhattar R. BRCA1 is associated with a human SWI/SNF-related complex: linking chromatin remodeling to breast cancer. Cell. 102:2000;257-265.
94. Phelan M.L., Schnitzler G.R., Kingston R.E. Octamer transfer and creation of stably remodeled nucleosomes by human SWI-SNF and its isolated ATPases. Mol. Cell. Biol. 20:2000;6380-6389.
95. Havas K., Flaus A., Phelan M., Kingston R., Wade P.A., Lilley D.M., Owen-Hughes T. Generation of superhelical torsion by ATP-dependent chromatin remodeling activities. Cell. 103:2000;1133-1142.
96. Aalfs J.D., Narlikar G.J., Kingston R.E. Functional differences between the human ATP-dependent nucleosome remodeling proteins BRG1 and SNF2H. J. Biol. Chem. 276:2001;34270-34278.
97. Otsuki T., Furukawa Y., Ikeda K., Endo H., Yamashita T., Shinohara A., Iwamatsu A., Ozawa K., Liu J.M. Fanconi anemia protein, FANCA, associates with BRG1, a component of the human SWI/SNF complex. Hum. Mol. Genet. 10:2001;2651-2660.
98. Folias A., Matkovic M., Bruun D., Reid S., Hejna J., Grompe M., D'Andrea A., Moses R. BRCA1 interacts directly with the Fanconi anemia protein FANCA. Hum. Mol. Genet. 11:2002;2591-2597.
99. Vandenberg C.J., Gergely F., Ong C.Y., Pace P., Mallery D.L., Hiom K., Patel K.J. BRCA1-independent ubiquitination of FANCD2. Mol. Cell. 12:2003;247-254.
100. Jin S., Mao H., Schnepp R.W., Sykes S.M., Silva A.C., D'Andrea A.D., Hua X. Menin associates with FANCD2, a protein involved in repair of DNA damage. Cancer Res. 63:2003;4204-4210.
101. McMahon L.W., Sangerman J., Goodman S.R., Kumaresan K., Lambert M.W. Human alpha spectrin II and the FANCA, FANCC, and FANCG proteins bind to DNA containing psoralen interstrand cross-links. Biochemistry. 40:2001;7025-7034.
102. McMahon L.W., Walsh C.E., Lambert M.W. Human alpha spectrin II and the Fanconi anemia proteins FANCA and FANCC interact to form a nuclear complex. J. Biol. Chem. 274:1999;32904-32908.
103. Sridharan D., Brown M., Lambert W.C., McMahon L.W., Lambert M.W. Nonerythroid alphaII spectrin is required for recruitment of FANCA and XPF to nuclear foci induced by DNA interstrand cross-links. J. Cell Sci. 116:2003;823-835.
104. Meetei A.R., Sechi S., Wallisch M., Yang D., Young M.K., Joenje H., Hoatlin M.E., Wang W. A multiprotein nuclear complex connects Fanconi anemia and Bloom syndrome. Mol. Cell. Biol. 23:2003;3417-3426.
105. Nakanishi K., Taniguchi T., Ranganathan V., New H.V., Moreau L.A., Stotsky M., Mathew C.G., Kastan M.B., Weaver D.T., D'Andrea A.D. Interaction of FANCD2 and NBS1 in the DNA damage response. Nat. Cell Biol. 4:2002;913-920.
106. Stewart G.S., Wang B., Bignell C.R., Taylor A.M., Elledge S.J. MDC1 is a mediator of the mammalian DNA damage checkpoint. Nature. 421:2003;961-966.
107. Cumming R.C., Lightfoot J., Beard K., Youssoufian H., O'Brien P.J., Buchwald M. Fanconi anemia group C protein prevents apoptosis in hematopoietic cells through redox regulation of GSTP1. Nat. Med. 7:2001;814-820.
108. Kruyt F.A., Youssoufian H. Do Fanconi anemia genes control cell response to cross-linking agents by modulating cytochrome P-450 reductase activity? Drug Resist. Updat. 3:2000;211-215.
109. Pang Q., Keeble W., Christianson T.A., Faulkner G.R., Bagby G.C. FANCC interacts with Hsp70 to protect hematopoietic cells from IFN-gamma/TNF-alpha- mediated cytotoxicity. EMBO J. 20:2001;4478-4489.
110. Futaki M., Igarashi T., Watanabe S., Kajigaya S., Tatsuguchi A., Wang J., Liu J.M. The FANCG Fanconi anemia protein interacts with CYP2E1: possible role in protection against oxidative DNA damage. Carcinogenesis. 23:2002;67-72.
111. Buchwald M., Moustacchi E. Is Fanconi anemia caused by a defect in the processing of DNA damage? Mutat. Res. 408:1998;75-90.
112. Fujiwara Y., Tatsumi M. Cross-link repair in human cells and its possible defect in Fanconi's anemia cells. J. Mol. Biol. 113:1977;635-649.
113. Fujiwara Y. Defective repair of mitomycin C crosslinks in Fanconi's anemia and loss in confluent normal human and xeroderma pigmentosum cells. Biochim. Biophys. Acta. 699:1982;217-225.
114. Fornace A.J. Jr, Little J.B., Weichselbaum R.R. DNA repair in a Fanconi's anemia fibroblast cell strain. Biochim. Biophys. Acta. 561:1979;99-109.
115. Poll E.H., Arwert F., Kortbeek H.T., Eriksson A.W. Fanconi anaemia cells are not uniformly deficient in unhooking of DNA interstrand crosslinks, induced by mitomycin C or 8-methoxypsoralen plus UVA. Hum. Genet. 68:1984;228-234.
116. Poll E.H., Abrahams P.J., Arwert F., Eriksson A.W. Host-cell reactivation of cis-diamminedichloroplatinum(II)-treated SV40 DNA in normal human, Fanconi anaemia and xeroderma pigmentosum fibroblasts. Mutat. Res. 132:1984;181-187.
117. Sognier M.A., Hittelman W.N. Loss of repairability of DNA interstrand crosslinks in Fanconi's anemia cells with culture age. Mutat. Res. 108:1983;383-393.
118. Sun Y., Moses R.E. Reactivation of psoralen-reacted plasmid DNA in Fanconi anemia, xeroderma pigmentosum, and normal human fibroblast cells. Somat. Cell Mol. Genet. 17:1991;229-238.
119. Rey J.P., Scott R., Muller H. Induction and removal of interstrand crosslinks in the ribosomal RNA genes of lymphoblastoid cell lines from patients with Fanconi anemia. Mutat. Res. 289:1993;171-180.
120. Dean S.W., Sykes H.R., Lehmann A.R. Inactivation by nitrogen mustard of plasmids introduced into normal and Fanconi's anaemia cells. Mutat. Res. 194:1988;57-63.
121. Smith J., Andrau J.C., Kallenbach S., Laquerbe A., Doyen N., Papadopoulo D. Abnormal rearrangements associated with V(D)J recombination in Fanconi anemia. J. Mol. Biol. 281:1998;815-825.
122. Papadopoulo D., Laquerbe A., Guillouf C., Moustacchi E. Molecular spectrum of mutations induced at the HPRT locus by a cross-linking agent in human cell lines with different repair capacities. Mutat. Res. 294:1993;167-177.
123. Papadopoulo D., Guillouf C., Porfirio B., Moustacchi E. Decreased mutagenicity in Fanconi's anemia lymphoblasts following treatment with photoactivated psoralens. Prog. Clin. Biol. Res. 340A:1990;241-248.
124. Papadopoulo D., Guillouf C., Mohrenweiser H., Moustacchi E. Hypomutability in Fanconi anemia cells is associated with increased deletion frequency at the HPRT locus. Proc. Natl. Acad. Sci. USA. 87:1990;8383-8387.
125. Guillouf C., Laquerbe A., Moustacchi E., Papadopoulo D. Mutagenic processing of psoralen monoadducts differ in normal and Fanconi anemia cells. Mutagenesis. 8:1993;355-361.
126. Guillouf C., Moustacchi E., Papadopoulo D. HPRT gene expression differs in mutants derived from normal and Fanconi anemia cells: analysis of spontaneous and psoralen-photoinduced mutants. Somat. Cell Mol. Genet. 17:1991;591-599.
127. Escarceller M., Buchwald M., Singleton B.K., Jeggo P.A., Jackson S.P., Moustacchi E., Papadopoulo D. Fanconi anemia C gene product plays a role in the fidelity of blunt DNA end-joining. J. Mol. Biol. 279:1998;375-385.
128. Escarceller M., Rousset S., Moustacchi E., Papadopoulo D. The fidelity of double strand breaks processing is impaired in complementation groups B and D of Fanconi anemia, a genetic instability syndrome. Somat. Cell Mol. Genet. 23:1997;401-411.
129. Thyagarajan B., Campbell C. Elevated homologous recombination activity in Fanconi anemia fibroblasts. J. Biol. Chem. 272:1997;23328-23333.
130. Jasin M. Homologous repair of DNA damage and tumorigenesis: the BRCA connection. Oncogene. 21:2002;8981-8993.
131. Moynahan M.E., Chiu J.W., Koller B.H., Jasin M. Brca1 controls homology-directed DNA repair. Mol. Cell. 4:1999;511-518.
132. Moynahan M.E., Cui T.Y., Jasin M. Homology-directed DNA repair, mitomycin-c resistance, and chromosome stability is restored with correction of a Brca1 mutation. Cancer Res. 61:2001;4842-4850.
133. Moynahan M.E., Pierce A.J., Jasin M. BRCA2 is required for homology-directed repair of chromosomal breaks. Mol. Cell. 7:2001;263-272.
134. Haber J.E. The many interfaces of Mre11. Cell. 95:1998;583-586.
135. Jeggo P.A. Identification of genes involved in repair of DNA double-strand breaks in mammalian cells. Radiat. Res. 150:1998;S80-S91.
136. Zhu J., Petersen S., Tessarollo L., Nussenzweig A. Targeted disruption of the Nijmegen breakage syndrome gene NBS1 leads to early embryonic lethality in mice. Curr. Biol. 11:2001;105-109.
137. Yamaguchi-Iwai Y., Sonoda E., Sasaki M.S., Morrison C., Haraguchi T., Hiraoka Y., Yamashita Y.M., Yagi T., Takata M., Price C., Kakazu N., Takeda S. Mre11 is essential for the maintenance of chromosomal DNA in vertebrate cells. EMBO J. 18:1999;6619-6629.
138. Luo G., Yao M.S., Bender C.F., Mills M., Bladl A.R., Bradley A., Petrini J.H. Disruption of mRad50 causes embryonic stem cell lethality, abnormal embryonic development, and sensitivity to ionizing radiation. Proc. Natl. Acad. Sci. USA. 96:1999;7376-7381.
139. Ludwig T., Chapman D.L., Papaioannou V.E., Efstratiadis A. Targeted mutations of breast cancer susceptibility gene homologs in mice: lethal phenotypes of Brca1, Brca2, Brca1/Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos. Genes Dev. 11:1997;1226-1241.
140. Xiao Y., Weaver D.T. Conditional gene targeted deletion by Cre recombinase demonstrates the requirement for the double-strand break repair Mre11 protein in murine embryonic stem cells. Nucleic Acids Res. 25:1997;2985-2991.
141. Tsuzuki T., Fujii Y., Sakumi K., Tominaga Y., Nakao K., Sekiguchi M., Matsushiro A., Yoshimura Y., Morita T. Targeted disruption of the Rad51 gene leads to lethality in embryonic mice. Proc. Natl. Acad. Sci. USA. 93:1996;6236-6240.
142. Chen M., Tomkins D.J., Auerbach W., McKerlie C., Youssoufian H., Liu L., Gan O., Carreau M., Auerbach A., Groves T., Guidos C.J., Freedman M.H., Cross J., Percy D.H., Dick J.E., Joyner A.L., Buchwald M. Inactivation of Fac in mice produces inducible chromosomal instability and reduced fertility reminiscent of Fanconi anaemia. Nat. Genet. 12:1996;448-451.
143. Cheng N.C., van de Vrugt H.J., van der Valk M.A., Oostra A.B., Krimpenfort P., de Vries Y., Joenje H., Berns A., Arwert F. Mice with a targeted disruption of the Fanconi anemia homolog Fanca. Hum. Mol. Genet. 9:2000;1805-1811.
144. Whitney M.A., Royle G., Low M.J., Kelly M.A., Axthelm M.K., Reifsteck C., Olson S., Braun R.E., Heinrich M.C., Rathbun R.K., Bagby G.C., Grompe M. Germ cell defects and hematopoietic hypersensitivity to gamma-interferon in mice with a targeted disruption of the Fanconi anemia C gene. Blood. 88:1996;49-58.
145. Yang Y., Kuang Y., De Oca R.M., Hays T., Moreau L., Lu N., Seed B., D'Andrea A.D. Targeted disruption of the murine Fanconi anemia gene, Fancg/Xrcc9. Blood. 98:2001;3435-3440.
146. Houghtaling S., Timmers C., Noll M., Finegold M.J., Jones S.N., Meyn M.S., Grompe M. Epithelial cancer in Fanconi anemia complementation group D2 (Fancd2) knockout mice. Genes Dev. 17:2003;2021-2035.